pojokkampung.org-Universitas Gadjah Mada (UGM) officially handed over the technology for the detection of Covid-19 through a breath which is named GeNose to the Ministry of Research and Technology / National Agency for Research and Technology, Thursday (24/9).
The Covid-19 detection tool developed by UGM researchers has the ability to detect the new corona virus in the human body in a fast time. No less than 2 minutes of the test results can be seen whether positive or negative Covid-19.
"Previously it took about 3 minutes, yesterday when testing at BIN it could drop to 80 seconds so that it is even faster," said a member of the GeNose research team, Kuwat Triyono, at the GeNose Public Expose: Covid-19 Sniffing Technology at the BJ Habibie Building. 24th floor, Jakarta.
Apart from being quick to detect and having high accuracy, the use of this tool is much more affordable than the PCR swab test. One GeNose unit, which is estimated to cost Rp. 40 million, can be used for 100 thousand inspections.
"For now, the optimum production capacity is around 50 thousand units per month," he said.
Another GeNose researcher, Dian Kesumapramudya Nurputra, explained that GeNose works to detect Volatile Organic Compound (VOC) which is formed due to a Covid-19 infection that comes out with the breath through exhalation of breath into a special bag. Furthermore, it is identified through sensors, which then the data will be processed with the help of artificial intelligence (Artificial Intelligence).
GeNose has gone through a profiling test using 600 samples of valid data at the Bhayangkara Hospital and the Covid Bambanglipuro Special Field Hospital in Yogyakarta. The results show a high level of accuracy, namely 97 percent. After going through the first phase of clinical trials, GeNose is currently entering the second phase of clinical trials.
The Minister of Research and Technology / National Agency for Research and Innovation, Bambang Brodjonegoro, appreciated the Covid-19 detection tool developed by the UGM research team. He said his party was ready to support GeNose's continued clinical trials.
"Research / National Agency for Research and Innovation through the Covid-19 Research and Innovation Consortium is ready to provide support for GeNose finalization efforts in the form of supporting phase 2 clinical trials," he said.
He hopes that GeNose can soon be used massively by the community. He targets that at least December 2020 this tool can be used for screening."If you have clinical trials and get a distribution permit from the Ministry of Health, make sure that the tools delivered to the Task Force can be used as test kits to help Indonesia's efforts to increase the testing ratio," he said.
During the GeNose handover ceremony, UGM Deputy Chancellor for Cooperation and Alumni, Paripurna Sugarda, along with the entourage, Deputy for Intelligence Technology BIN, Maj. Gen. Afini Boer, Head of the Republic of Indonesia Police Medical and Health Center, Brigadier General Pol Rusdianto, Chair of the Research Consortium and the Covid-19 Innovation Ministry of Research and Technology / National Agency for Research and Innovation, Ali Ghufron Mukti, Plt. Deputy for Strengthening Research and Development of the Ministry of Research and Technology / National Agency for Research and Innovation, Muhammad Dimyati, representative of the supporting industry for GeNose.
0 Comments